Related by context. All words. (Click for frequent words.) 78 CR# vcMMAE 77 PSMA ADC 76 alvespimycin 76 huC# DM4 75 oral prodrug 75 mertansine 75 INCB# [001] 74 Archexin 74 OXi# 74 orally administered inhibitor 74 ENMD # 74 HCV protease inhibitor 74 SAR# [004] 73 telomerase therapeutic 73 PXD# 73 CCX# 73 Sym# 73 HCD# [002] 73 Azedra 73 MAGE A3 ASCI 73 proteasome inhibitor 73 ganetespib 73 ZOLINZA 73 Bezielle 73 Panzem R NCD 73 YONDELIS 73 forodesine 73 #I TM# 73 CEQ# 73 mapatumumab 72 Panzem R 72 metaglidasen 72 IL# PE#QQR 72 CA4P 72 fosbretabulin 72 GRNVAC1 72 PRT# 72 investigational humanized monoclonal antibody 72 Carfilzomib 72 elotuzumab 72 Tarceva TM 72 targeted radiotherapeutic 72 Zybrestat 72 Panzem 72 OMP #M# 72 AQ4N 72 APOPTONE 72 pomalidomide 72 HuMax EGFr 72 samalizumab 72 GRN#L 72 FOLOTYN ® 72 PDE4 inhibitor 72 R#/MEM # 72 Chemophase 72 JAK inhibitor 72 Romidepsin 72 Phase 2b Clinical Trial 72 TBC# 72 CD# CEA 72 HQK 71 HGS# 71 PLK1 SNALP 71 ALN PCS 71 Aflibercept 71 pan HDAC inhibitor 71 vidofludimus 71 LY# [003] 71 Pimavanserin 71 CYC# 71 trastuzumab DM1 T DM1 71 Pazopanib 71 IMC #B 71 TELINTRA 71 Golimumab 71 Elotuzumab 71 favorable pharmacokinetic profile 71 Nanobody 71 phase IIb clinical 71 HGS ETR2 71 TG# [003] 71 Symadex 71 anticancer compound 71 TKM ApoB 71 Trofex 71 histone deacetylase inhibitor 71 TACI Ig 71 MGd 71 novel peptide 71 PEGylated interferon 71 Triolex 71 CRLX# 71 delafloxacin 71 obatoclax 71 novel VDA molecule 71 RGB # 71 GVAX ® 71 systemic RNAi therapeutic 71 paclitaxel Taxol ® 71 oral picoplatin 71 CYT# potent vascular disrupting 71 HDAC Inhibitor 71 angiogenesis inhibitor 71 preclinically 71 Apoptone 71 Virulizin ® 70 Dapagliflozin 70 HGS ETR1 70 histone deacetylase HDAC inhibitor 70 BAY #-# 70 MEK inhibitors 70 GW# [003] 70 Quinamed 70 Androxal TM 70 Enzastaurin 70 liposomal formulation 70 Dasatinib 70 seliciclib CYC# 70 Omacetaxine 70 pertuzumab 70 Pertuzumab 70 IMA# 70 Sapacitabine 70 investigational monoclonal antibody 70 oral ridaforolimus 70 Traficet EN 70 non nucleoside inhibitor 70 PEG Interferon lambda 70 evaluating tivozanib 70 OvaRex R 70 telomerase inhibitor drug 70 thalidomide Thalomid 70 Phase Ib study 70 midstage clinical 70 orally dosed 70 AEG# 70 IMC A# 70 indibulin 70 Tarvacin TM 70 Phase Ib II 70 cediranib 70 CINTREDEKIN BESUDOTOX 70 Vitaxin 70 subcutaneous formulation 70 KNS # 70 docetaxel Taxotere ® 70 urocortin 2 70 tanespimycin 70 ALN TTR 70 selective modulator 70 enzastaurin 70 erlotinib Tarceva ® 70 docetaxel Taxotere R 70 tubulin inhibitor 70 generation purine nucleoside 70 PSN# [002] 70 ISTODAX 70 NV1FGF 70 HuLuc# 70 ZK EPO 70 Curaxin 70 Phase #b/#a clinical 70 CBLC# 70 rNAPc2 70 EZN 70 EndoTAG TM -1 70 #D#C# 70 Onconase 70 huN# DM1 70 demonstrated antitumor activity 70 volociximab 70 preclinical efficacy 69 CoFactor 69 cannabinor 69 Factor VIIa 69 Tanespimycin 69 AP# [003] 69 XmAb# 69 trastuzumab DM1 69 deforolimus 69 neratinib 69 nonclinical studies 69 Pivotal Phase III 69 Aplidin 69 oncolytic virus therapies 69 Darinaparsin 69 sitaxsentan 69 MGCD# [001] 69 Capesaris 69 GLP toxicology studies 69 Amrubicin 69 virus HCV protease inhibitor 69 cMET 69 ZYBRESTAT 69 Annamycin 69 relapsed MM 69 Tezampanel 69 SinuNase ™ 69 eniluracil 69 candidate CRLX# 69 MEK inhibitor 69 axitinib 69 Thiovir 69 IMiDs 69 JAK2 inhibitor 69 Phase 2a trial 69 novel histone deacetylase 69 Aplidin R 69 velafermin 69 AAG geldanamycin analog 69 Dacogen injection 69 PI3K/Akt pathway inhibitor 69 lumiliximab 69 phase IIa clinical 69 phase IIb trial 69 Talabostat 69 adecatumumab MT# 69 receptor tyrosine kinase inhibitor 69 radezolid 69 cilengitide 69 Vicriviroc 69 IAP inhibitors 69 Hsp# Inhibitor 69 RhuDex ® 69 IMiDs R 69 SPRYCEL ® 69 Voreloxin 69 CIMZIA TM 69 milatuzumab 69 crizotinib PF # 69 ZACTIMA 69 Presents Preclinical Data 69 Trastuzumab 69 Personalized Immunotherapy 69 pharmacodynamic properties 69 IMiDs ® 69 non nucleoside HCV 69 multitargeted 69 ongoing Phase 1b 69 rxRNA 69 riociguat 69 vascular disrupting agent 69 Pralatrexate 69 Atiprimod 69 preclinical pharmacokinetic 69 Genasense ® oblimersen 69 mGluR2 NAM 69 NEUGENE 69 PEGPH# 69 OHR/AVR# 69 thymalfasin 69 THR beta agonist 69 PKC# 69 Phenoptin 69 TLK# 69 R roscovitine 69 Bicifadine 69 Aliskiren 69 Glufosfamide 69 DXL# 69 Vandetanib 69 Targretin 69 Tyrima 69 Cloretazine ® 69 Ridaforolimus 69 sapacitabine 69 ularitide 69 ixabepilone 69 generation URAT1 inhibitor 69 JAK1 69 CIMZIA ™ 69 Rigel R# 69 mGluR5 NAM 69 Initiates Clinical 69 IgG1 monoclonal antibody 69 velafermin belinostat 69 Seliciclib 69 TRO# 69 generation Hsp# inhibitor 69 trastuzumab Herceptin R 69 adalimumab Humira 69 budesonide foam 69 SERMs 69 PNT# 68 interferon gamma 1b 68 Alzhemed TM 68 cancer immunotherapies 68 GAMMAGARD 68 ALN HPN 68 teduglutide 68 lapatinib Tykerb 68 Phase 2b Trial 68 IRX 2 68 Daclizumab 68 lenalidomide Revlimid R 68 CORT # 68 PDX pralatrexate 68 Exherin TM 68 PS# [001] 68 teriflunomide 68 vinca alkaloid 68 CG# [003] 68 #ME# 68 ocular formulation 68 XL# XL# 68 Nanobody ® 68 Safinamide 68 Sudhir Agrawal D.Phil 68 bevacizumab Avastin ® 68 multi kinase inhibitor 68 Zorbtive TM 68 LEP ETU 68 CTAP# Capsules 68 ALN VSP 68 HSP# inhibitor 68 dacetuzumab 68 nucleoside analog 68 Civacir 68 Trofex TM 68 EOquin TM 68 Xanafide 68 TKB# 68 PNP inhibitor 68 Mipomersen 68 Rebif ® 68 Solazed TM 68 ospemifene 68 Phase Ib clinical 68 Antitumor Activity 68 CD# monoclonal antibody 68 DAVANAT 68 GAP #B# 68 ISIS # 68 Aurora Kinase 68 AKT inhibitor 68 CD# antibody [001] 68 MOZOBIL 68 Alocrest 68 Reports Preclinical Data 68 Panzem NCD 68 midstage trials 68 vaccine GRNVAC1 68 lorvotuzumab mertansine 68 VitiGam 68 talabostat 68 hypoxia selective 68 Afatinib 68 sorafenib tablets 68 oral methylnaltrexone 68 Tesetaxel 68 Protexia ® 68 APTIVUS 68 5 Fluorouracil 68 Enzyme Replacement Therapy 68 selective androgen receptor modulator 68 MCSP respectively 68 seliciclib 68 glucokinase activator 68 Genz # 68 nab paclitaxel 68 Phase 2a Clinical Trial 68 maximally tolerated dose 68 BZL# 68 OMP #R# 68 PD LID 68 Meets Primary Endpoint 68 PRTX 68 oral Azacitidine 68 Eculizumab 68 HuMax CD4 68 Immunotherapeutic 68 IAP inhibitor 68 imatinib Gleevec ® 68 humanized anti 68 eltrombopag 68 TOCOSOL Paclitaxel 68 Plicera 68 lintuzumab SGN 68 decitabine 68 GALNS 68 PANVAC VF 68 lucinactant 68 epigenetic therapies 68 OncoVEX 68 Blinatumomab 68 Maribavir 68 Zolinza 68 Pegloticase 68 Initiate Phase 68 ocrelizumab 68 Phase IIIb clinical 68 vascular disrupting agents 68 mitogen activated ERK kinase 68 PORxin TM 68 triphendiol 68 2 methoxyestradiol 68 alkylating agent 68 MAP# 68 Fx #A 68 BRAF inhibitor 68 HER2 positive metastatic breast 68 radiation sensitizer 68 Troxatyl 68 Phase #/#a trial 68 Phase III Pivotal 68 alpha antagonist 68 LT NS# 68 depsipeptide 68 dextromethorphan quinidine 68 Phase IIb Clinical Trial 68 ThermoDox ® clinical 68 OncoVEX GM CSF 67 Angiocept 67 CCR9 antagonist 67 Talactoferrin 67 Proxinium TM 67 hA# 67 Phase IIb clinical trials 67 HCV protease inhibitors 67 Degarelix 67 Zalypsis 67 HIF PHI 67 elacytarabine 67 JAK inhibitors 67 atacicept 67 LEUKINE 67 TELCYTA 67 MKC# MT 67 Aurexis 67 CYT# 67 AMD# [003] 67 cetuximab Erbitux R 67 Telbivudine 67 antitumor effects 67 RLY# 67 Novel Oral 67 MAXY G# 67 HuMax CD# 67 torezolid phosphate 67 oral proteasome inhibitor 67 Advaxis Phase 67 MEK Inhibitor 67 anti amnesic 67 Gliadel Wafer 67 UPLYSO 67 Antiangiogenic 67 GAMMAGARD LIQUID 67 Aurora kinase 67 MAXY alpha 67 visilizumab 67 cisplatin gemcitabine 67 Muraglitazar 67 protein kinase inhibitor 67 Amplimexon 67 EGFR HER2 67 Phase 1b trial 67 small molecule tyrosine 67 Xcytrin R 67 Nexavar ® 67 Darusentan 67 highly selective inhibitor 67 IMGN# 67 investigational pan BCR 67 PEG PAL 67 antiangiogenic activity 67 pegylated liposomal doxorubicin 67 ORENCIA R 67 INC# 67 Imprime PGG 67 masitinib 67 INSPIRE Trial Phase III 67 Ixabepilone 67 registrational trial 67 VEGF Trap 67 REOLYSIN ® 67 Neulasta ® 67 Ocrelizumab 67 tolevamer 67 ASG 5ME 67 refractory gout 67 Metastatic Melanoma 67 Teriflunomide 67 sapacitabine CYC# 67 MNTX 67 sorafenib Nexavar 67 AVE# 67 Thiarabine 67 Velcade bortezomib 67 antibody MAb 67 Tarvacin 67 ELACYT 67 XYOTAX TM 67 Guanilib 67 CCR5 antagonist 67 adecatumumab 67 lomitapide 67 Bafetinib 67 Pivotal Phase 67 Kinase Inhibitor 67 solithromycin 67 TRAIL receptor antibodies 67 IMMU 67 BRIM2 67 Bortezomib 67 next generation URAT1 67 Antibody Drug Conjugate 67 accumulate preferentially 67 targeted antifolate 67 cobiprostone 67 squalamine 67 immunomodulator 67 gamma secretase inhibitor 67 regorafenib 67 sunitinib Sutent ® 67 TOLAMBA 67 Epratuzumab 67 motesanib 67 Fibrillex TM 67 novel topoisomerase 67 Fodosine 67 beta 1a 67 PCK# 67 hypoxia activated prodrug 67 GRN# 67 flavopiridol 67 otelixizumab 67 TRX1 67 investigational hepatitis C 67 busulfan 67 vorinostat 67 systemically administered 67 brivaracetam 67 herpetic keratitis 67 Zerenex 67 PrevOnco ™ 67 registrational 67 Xelox 67 phase IIb study 67 phase IIb 67 Intravenous CP 67 targeting CD# 67 Myocet 67 PROSTVAC VF 67 OvaRex ® MAb 67 dasatinib Sprycel ® 67 ONCASPAR 67 Aurora kinase inhibitor 67 Perifosine 67 nalbuphine ER 67 Temsirolimus 67 Vidofludimus 67 drug conjugate 67 Ixempra 67 Cloretazine 67 etanercept Enbrel 67 TPI ASM8 67 Ophena TM 67 telaprevir VX 67 Azedra TM 67 torezolid 67 Romiplostim 67 vivo validation 67 trastuzumab Herceptin 67 ritonavir boosted 67 aplindore 67 Xcellerated T Cells 67 Shigamabs ® 67 synthetic retinoid 67 ATL# [001] 67 Phase IIb Trial 67 LAF# 67 Belinostat 67 Phase Ib clinical trials 67 panitumumab Vectibix 67 chimeric monoclonal antibody 67 FOLFOX chemotherapy 67 gefitinib Iressa 67 Phase #b/#a 67 Pemetrexed 67 tezampanel 67 Fludara ® 67 MYDICAR ® 67 histone deacetylase HDAC 67 CCR5 mAb 67 KRN# 67 Platinol ® cisplatin 67 antiangiogenic 67 docetaxel chemotherapy 67 Protexia R 67 LibiGel ® 66 Zenvia Phase III 66 LymphoStat B 66 dexpramipexole 66 Combination REOLYSIN R 66 omega interferon 66 Asentar 66 AeroLEF TM 66 MT#/MEDI-# 66 Cethromycin 66 Matrix Phase 2b 66 Cloretazine R VNP#M 66 administered subcutaneously 66 pharmacokinetic PK study 66 ARIKACE 66 Valortim R 66 HDL Selective Delipidation 66 EGS# 66 CD# expressing 66 long acting muscarinic 66 RNAi Therapeutic 66 NP2 Enkephalin 66 Gleevec resistant 66 PI3K/mTOR 66 multicenter Phase II 66 cetuximab Erbitux 66 evaluating satraplatin 66 mecamylamine 66 alefacept 66 XL# SAR# 66 Investigational Compound 66 CDDO Im 66 rhIL 7 66 ZYBRESTAT fosbretabulin 66 RhuDex 66 GVAX R 66 Cleviprex TM clevidipine 66 CDK inhibitor 66 cleavable linker 66 Onco TCS 66 ALN TTR# 66 Solazed 66 TOCOSOL Camptothecin 66 tafamidis 66 peginesatide 66 refractory chronic lymphocytic 66 Phase 1a clinical 66 Vilazodone 66 INT# [002] 66 DermaVir Patch 66 selective kinase inhibitor 66 veltuzumab 66 Tyrosine Kinase Inhibitor 66 Ozarelix 66 selective inhibition 66 kidney urologic 66 Evoltra ® 66 paclitaxel Taxol R 66 hematological indications 66 EGEN 66 PrevOnco 66 DOS# 66 immunotherapeutic agent 66 Kahalalide F 66 pralatrexate 66 octreotide acetate 66 XOMA 3AB 66 omacetaxine mepesuccinate 66 BRAF inhibitors 66 Lenocta 66 Squalamine 66 BCX# 66 acetonide FA 66 Lovaxin C 66 Tesmilifene 66 pemetrexed Alimta 66 Telik logo TELINTRA 66 Completes Patient Enrollment 66 romidepsin 66 Zemiva TM 66 cetuximab Erbitux ® 66 pharmacokinetic interactions 66 Forodesine HCl 66 Initiates Phase II 66 Phase IIa trial 66 estramustine 66 isoform selective 66 Abiraterone acetate 66 THALOMID 66 oral antiviral 66 Ceflatonin 66 imetelstat 66 Elagolix 66 Deforolimus 66 PHX# 66 MKC# MKC# PP 66 viral kinetics 66 JAK Inhibitor 66 BioNumerik 66 tramiprosate Alzhemed TM 66 CGEN # 66 taxane resistant 66 gemcitabine cisplatin 66 sodium Injection 66 Preclinical studies suggest 66 Tß4 66 NVA# 66 sunitinib Sutent 66 TKM PLK1 66 GLPG# 66 reslizumab 66 acyclovir Lauriad R 66 Solazed ™ 66 Presents Preclinical 66 incyclinide 66 HGS ETR1 mapatumumab 66 galiximab 66 TNF Tumor Necrosis Factor 66 metastatic castration resistant 66 Phase III Clinical Trial 66 R Saizen R 66 tarenflurbil 66 tipifarnib 66 Irinotecan 66 aleglitazar 66 tiapamil 66 CRMD# 66 leading oral taxane 66 SCH # 66 rilonacept 66 BIM #A# 66 sunitinib malate 66 vandetanib 66 IV Busulfex 66 therapeutic monoclonal antibody 66 Allovectin 7 66 HCV polymerase inhibitors 66 Lixivaptan 66 DU #b 66 5 fluorouracil leucovorin 66 Phase IIb trials 66 Menadione 66 paclitaxel Taxol 66 Anavex #-# 66 Valortim ® 66 phase IIb III 66 Successfully Completes Phase 66 ICA # 66 PDE# inhibitors 66 orally bioavailable 66 PF # [002] 66 Hematide ™ 66 6R BH4 66 PEGylated interferon beta 1a 66 Tamibarotene 66 Varespladib 66 Initiate Clinical Trial 66 Allovectin 7 ® 66 HepeX B 66 metastatic colorectal 66 Aganocide ® 66 tigecycline 66 rituximab Rituxan 66 L BLP# 66 delta isoform 66 OMNARIS Nasal Spray 66 VEGFR2 inhibitor 66 subcutaneously administered 66 Interferon beta 1a 66 ELND# 66 prostone 66 ProSavin 66 lesinurad 66 Gemzar ® 66 MGCD# [002] 66 ON #.Na 66 phase Ib clinical 66 Preclinical Data 66 Lu AA# 66 Urocortin 2 66 nanopharmaceutical 66 IMiDs ® compound 66 investigational therapies 66 Pegasys ® 66 VA# [002] 66 Phase #/#a 66 Randomized Phase II 66 phase Ib 66 Ambrisentan 66 talactoferrin 66 Vascugel 66 Sphingomab 66 TNFerade TM 66 anticoagulant reversing agent 66 glufosfamide 66 TransVax TM 66 myelofibrosis polycythemia vera 66 Ramoplanin 66 XL# anticancer compounds 66 clevidipine 66 AVONEX ® 66 trodusquemine 66 Silodosin 66 zanolimumab 66 Fulvestrant 66 GTC recombinant human 66 bortezomib Velcade 66 EGFr 66 Lubiprostone 66 Proellex TM 66 RAPTIVA 66 cutaneous T 66 compound INCB# 66 Begins Dosing 66 Cutaneous T 66 Phase #b/#a trial 66 Celator 66 XP# XP# 66 adipiplon 66 Lisofylline LSF 66 AACR NCI EORTC 66 LY# [002] 66 Geron telomerase inhibitor 66 pegylated interferons 66 PROMACTA 66 polyglutamate 66 DiLA2 66 AZT zidovudine Retrovir 66 Telatinib 66 Nasulin ™ 66 GSK# [001] 66 severe hypercholesterolemia 66 Aganocide 66 custirsen 66 YONDELIS R 66 GSK# [002] 66 Cethrin R 66 Hedgehog antagonist 66 novel anticancer 66 Pradefovir 66 5 FU leucovorin 66 Triapine R 66 polymerase inhibitors 66 Spiegelmer ® 66 metastatic hormone refractory 66 isatoribine 66 HepeX B TM 66 Hepatotoxicity 66 ALN HTT 66 Alkeran 66 Excellarate 66 Initiates Enrollment 66 INCB# [002] 66 subcutaneous SC 66 ONTAK 65 protein tyrosine phosphatase 1B 65 S/GSK# 65 MEK inhibitor RDEA# 65 Clolar ® 65 refractory multiple myeloma 65 Actilon 65 DEB# 65 SUCCEED trial 65 pradefovir 65 daptomycin 65 phase III isavuconazole 65 GRNCM1 65 humanized monoclonal 65 nucleotide analog 65 ponatinib 65 Stedivaze 65 oral taxane 65 PRX # 65 TYZEKA 65 immune modulating 65 GMX# 65 VAPRISOL 65 Elvitegravir 65 Copegus ribavirin 65 P#X# antagonist 65 Nektar proprietary 65 Introgen ADVEXIN 65 NeuroSTAT ® 65 Aloxi injection 65 antiproliferative effects 65 Interferon Beta 65 Perforomist ™ Inhalation Solution 65 Arimoclomol 65 hoFH 65 ASONEP 65 initiated Phase Ib 65 Boceprevir 65 compound AEZS 65 phase IIa 65 prokinetic agent 65 Tasimelteon 65 recurrent glioblastoma multiforme 65 epothilone 65 Neurodex 65 dirucotide 65 ONCONASE R 65 BrachySil TM 65 EXPAREL TM 65 Omnitarg 65 davunetide intranasal AL 65 Anti Tumor 65 NS#/#A protease 65 GLYX 65 biologic therapeutics 65 anti leukemic 65 oxidative stress inducer 65 ThermoDox R 65 novel immunomodulatory 65 BiTE 65 bazedoxifene conjugated estrogens 65 Achieves Primary Endpoint 65 ENMD 65 CINQUIL 65 Pruvel 65 ZEVALIN ® 65 Initiates Clinical Trial 65 OMNARIS HFA 65 Granulocyte Colony Stimulating Factor 65 uric acid lowering 65 endothelin receptor antagonists 65 Methylnaltrexone 65 CB2 selective receptor agonist 65 rALLy clinical trial 65 intradermal injections 65 Campath ® 65 HCV polymerase 65 ANG# 65 Homspera TM 65 sargramostim 65 Octreotide 65 R sorafenib tablets 65 ACZ# 65 immunomodulatory therapy 65 PROSTVAC TM 65 CD4 monoclonal antibody 65 FavId 65 K ras mutations 65 refractory APL 65 Serdaxin 65 R#/MEM 65 NOX E# 65 Neuvenge 65 Liprostin 65 GSK # 65 Zenvia ™ 65 BiTE R 65 Aptivus ® 65 humanized monoclonal antibodies 65 SNT MC# 65 docetaxel Taxotere 65 SAR# [002] 65 TREANDA 65 aripiprazole Abilify 65 glucagon receptor 65 dosing cohort 65 QLT# 65 DPX Survivac 65 JAK3 65 anticancer activity 65 dasatinib Sprycel 65 Besivance 65 LymphoStat B TM 65 cysteamine bitartrate 65 KSP inhibitor 65 AMEVIVE 65 essential thrombocythemia ET 65 nitazoxanide 65 Telintra 65 adult mesenchymal stem 65 BHT DNA 65 SUTENT ® 65 corticosteroid dexamethasone 65 Virulizin R 65 RIGScan CR 65 Phase III Trials 65 novel oral anticoagulant 65 Preclinical Study 65 Saxagliptin 65 relapsed refractory multiple myeloma 65 potent anticancer 65 SPC# [001] 65 Nexavar sorafenib 65 HspE7 65 ApoB SNALP 65 Fast Track Status 65 FluCide 65 MYCAMINE 65 TASKi3 65 Trastuzumab DM1 65 plasma kallikrein inhibitor 65 ARRY # 65 DermaVir 65 MDV# 65 amrubicin 65 Nasulin 65 Exelixis XL# 65 alemtuzumab Campath 65 catheter occlusion 65 azilsartan medoxomil 65 Aryplase 65 pharmacodynamic markers 65 lexidronam injection 65 BAL# [002] 65 Small Molecule 65 Apixaban